Can fenelidone be taken long-term? Treatment cycle and patient medication recommendations

Finerenone (Finerenone) is a selective non-steroidal mineral corticoid receptor antagonist, mainly used to treat patients with chronic kidney disease (CKD) associated with type 2 diabetes. Clinical studies have shown that fenelidone can effectively slow down the progression of renal function deterioration and reduce the risk of cardiovascular events, so it has certain long-term use value in chronic treatment programs. However, whether it is suitable for long-term use depends on the patient's specific condition, tolerance, and regular evaluation results.

Normally, long-term use of fenelidone is recommended, especially for patients with high-risk diabetic nephropathy, to delay disease progression by continuously inhibiting the harmful effects of aldosterone. However, during long-term use, blood potassium levels and renal function (such as eGFR, creatinine, etc.) need to be tested regularly, because fenelidone may cause hyperkalemia or aggravate renal function damage. Especially when ACEI or ARB drugs are used in combination, closer monitoring is required.

There is no fixed course of treatment for fenelidone. As long as the patient tolerates the drug well, the treatment effect is significant, and the results of regular review are within the acceptable range, long-term maintenance treatment can be considered. Doctors usually decide whether to adjust the dose or discontinue the drug based on changes in the patient's kidney function and the occurrence of hyperkalemia. The frequency of follow-up visits may differ between the initial and stable stages of treatment, and treatment plans should also be managed individually.

In short, fenelidone is suitable for long-term use, but it must be followed up regularly under the guidance of a professional doctor, and the medication regimen must be adjusted based on test results. Patients should pay attention to diet control during medication, avoid excessive intake of high-potassium foods, and report physical discomfort in a timely manner. Scientific and standardized use of fenelidone will help improve the efficacy and reduce the risk of complications, and is an important part of the mid- and long-term management of patients with chronic kidney disease.

Reference materials:https://www.kerendia.com/